■ 学術雑誌
|
原著
|
|
1.
|
Jun Sato, Yuki Katsuya, Takafumi Koyama, Toshio Shimizu, Yasushi Tanoue, Maki Yamamoto, Hirokazu Tozaki, Eiji Takahara, Shingo Shoji, Akio Mizutani, Daisuke Morishita, Robert W Oda, Hiroshi Miyake, Kan Yonemori, Noboru Yamamoto：
Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research
：Online ahead of print
, 2026
|
|
2.
|
Hiroaki Kanemura, Junko Tanizaki, Koji Matsumoto, Toshiki Masuishi, Taichi Isobe, Hirotsugu Kenmotsu, Yu Sunakawa, Toshio Shimizu, Yasutaka Chiba, Nobuyuki Yamamoto, Kazuhiko Nakagawa, Hidetoshi Hayashi：
Phase Ia/Ib trial of the safety and efficacy of mobocertinib in combination with T-DM1 for patients with HER2-mutant solid tumors (WJOG16022M).
European journal of cancer (Oxford, England : 1990)
238
：116684
, 2026
|
|
3.
|
Tatsuki Ikoma, Keigo Araki, Mai Kitagawa, Natsuno Makihara, Yutaro Nagata, Kazuki Fujii, Yukiko Okuno, Keisuke Kamisako, Yuta Okazaki, Kentaro Nakanishi, Yume Sanada, Kiyori Yoshida, Kahori Nakahama, Yuki Takeyasu, Utae Katsushima, Yuta Yamanaka, Satoshi Ikeda, Hiroshige Yoshioka, Toshio Shimizu, Takayasu Kurata：
AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer.
Molecular therapy. Oncology
34
(3)
：201253
, 2026
|
|
